ClinicalTrials.gg

DrugSupplement

Selenomethionine clinical trials

studies test it
14
open now
0
in phase 3
1
first study started
2000

How studies write it

Studies that test it under each name

Studies by the year they started

14 studies that test it; most in 2008 (4)

Studies that test Selenomethionine, by start year
YearStudies
20001
20041
20061
20084
20091
20101
20121
20141
20161
20222

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
3
Phase 2
8
Phase 3
1
Phase 4
1
No phase
2

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 0 · Other 14

Roswell Park Cancer Institute (5) · Mohammed Milhem (2) · University of Auckland, New Zealand (1) · Aristotle University Of Thessaloniki (1) · Milton S. Hershey Medical Center (1) · SWOG Cancer Research Network (1) · Ege University (1) · University of Siena (1)

Often tested with

Tested in the same studies.

Axitinib (2) · Pembrolizumab (1) · Selenomethylselenocysteine (1) · Finasteride (1) · Carboplatin (1) · Paclitaxel (1) · Capecitabine (1) · Oxaliplatin (1)

Studies

Open first, then newest update. How each study uses Selenomethionine is read from its arms, and is right about nine times in ten.

Testing it · 14

Codes

What other systems call Selenomethionine · ClinicalTrials.gg INT008188

  • MeSH (NLM) D012645SelenomethionineOne source NLM
  • UNII (FDA) 964MRK2PELSELENOMETHIONINEConfirmed FDA, NLM, Wikidata
  • RxNorm 9644Confirmed FDA, Wikidata
  • Wikidata Q106314672L-selenomethionine zwitterionConfirmed FDA, NLM, Wikidata
  • Wikidata Q27096144L-selenomethionineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C2833L-SelenomethionineConfirmed FDA, Wikidata
  • DrugBank DB11142One source Wikidata

Also registered as selenomethionine se-75 (UNII P6708E7555 · RxNorm 9133).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.